InvestorsHub Logo
Followers 134
Posts 3749
Boards Moderated 0
Alias Born 01/28/2006

Re: DrBones post# 330368

Friday, 10/30/2020 10:37:44 AM

Friday, October 30, 2020 10:37:44 AM

Post# of 403091
I have sent the article to all my contacts too. My first read of the article shows Brilacidin performed better than I expected. Very high SI st micromolar concentrations. Synergy with Remdesivir and other antivirals. The RBL allowed IPIX to have a significant role in providing background information including a comment from Dr DeGrado.

My assessment is Brilacidin will be a useful treatment for Covid19. It effectiveness against Covid will reduce mortality and morbidity. It's good pharmacokinetics will allow infrequent dosing 2 to 3 at most. After the human trials are completed I expect an EUA and treatment on a worldwide scale. An inhaled form of Brilacidin will be studied soon as a preventative treatment for high risk individuals at the initiation of symptoms.

The risk of our investment in IPIX has been greatly reduced by this article and will open many doors.

Investors who recognize this opportunity will be greatly rewarded.

FDA trials, funding, partners are next milestones.

Imo

Good luck, Farrell


All my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News